U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181135) titled 'FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors' on Sept. 09.
Brief Summary: Study to demonstrate efficacy of finerenone when compared to placebo in reducing albuminuria in participants with chronic kidney disease (CKD) not using renin-angiotensin-system (RAS) inhibitors.
Study Start Date: Dec. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Disease
Intervention:
DRUG: Finerenone (BAY 94-8862)
Finerenone 10 or 20mg in participants with chronic kidney disease not using renin-angiotensin-system inhibitors
DRUG: Placebo
Placebo m...